Home > Healthcare > Medical Devices > Diagnostic Devices > Critical Care Diagnostics Market

Critical Care Diagnostics Market Share

Report ID: GMI9740
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Critical Care Diagnostics Market Share

The critical care diagnostics industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive diagnostic products with improved efficiency and affordability. This includes advancements in efficacy, precision, accuracy, and raw material. Competition is driven by factors such as the quality, reliability, and ease of usage along with integration capabilities with existing products, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Critical Care Diagnostics Market Companies

Some of the eminent market participants operating in the critical care diagnostics industry include:

Abbott Laboratories
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
GE HealthCare Technologies, Inc.
Hologic, Inc.
Johnson & Johnson
Koninklijke Philips N.V.
Medtronic plc
Nihon Kohden Corporation
Nova Biomedical
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Critical care diagnostics industry size was worth USD 1.3 billion in 2023 and will grow at 5.5% CAGR between 2024 and 2032 due to escalating prevalence of chronic diseases and infectious outbreaks coupled with the emphasis on early detection and intervention.

The glucose diagnostic kits segment in the market will record USD 507.2 million by 2032, driven by the rising prevalence of diabetes and the importance of monitoring glucose levels in critical care settings.

U.S. critical care diagnostics industry size will expand at 5.1% CAGR from 2024 to 2032, attributed to advanced healthcare infrastructure, extensive research and development activities, and a strong emphasis on technological innovation.

Key players operating in the critical care diagnostics industry are Danaher Corporation, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Hologic, Inc., Johnson & Johnson, Koninklijke Philips N.V., Medtronic plc, Nihon Kohden Corporation, and Nova Biomedical, among others.